Matthew Mishan, CFA

Matthew Mishan, CFA, is a Director and Equity Research Analyst specializing in Medical Technology at KeyBanc Capital Markets.12 He is based in New York and has over 500 connections on LinkedIn.1

Professional Background

Mishan's research coverage is primarily focused on medical products companies.2 As an equity research analyst, he provides insights and analysis on stocks within the healthcare sector, particularly in medical technology.3

Expertise and Recognition

Matthew Mishan holds the Chartered Financial Analyst (CFA) designation, which is a prestigious credential in the investment and financial analysis field.1 According to TipRanks, a platform that rates financial analysts, Mishan is considered a 3.28-star Wall Street Analyst.3 His analysis covers 32 stocks in the healthcare sector, and he has achieved a 52.84% success rate in his recommendations.3

Career at KeyBanc Capital Markets

At KeyBanc Capital Markets, Mishan has progressed in his career:

• He currently holds the position of Director, Equity Research Analyst.1
• Previously, he served as a Vice President in Equity Research.2

KeyBanc Capital Markets is a well-established financial services firm, and Mishan's role involves providing valuable insights to investors and clients interested in the medical technology sector.